Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19: Public Compliance with and Public Support for Stay-at-Home Mitigation Strategies

View ORCID ProfileMark É. Czeisler, View ORCID ProfileMark E. Howard, View ORCID ProfileRebecca Robbins, View ORCID ProfileLaura K. Barger, View ORCID ProfileElise R. Facer-Childs, View ORCID ProfileShantha M. W. Rajaratnam, View ORCID ProfileCharles A. Czeisler
doi: https://doi.org/10.1101/2020.04.22.20076141
Mark É. Czeisler
1School of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Melbourne, Victoria 3800 Australia
2Institute for Breathing and Sleep, Austin Health, Melbourne, Victoria 3084 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark É. Czeisler
Mark E. Howard
1School of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Melbourne, Victoria 3800 Australia
2Institute for Breathing and Sleep, Austin Health, Melbourne, Victoria 3084 Australia
3Department of Medicine, University of Melbourne, Melbourne, Victoria 3010 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark E. Howard
Rebecca Robbins
4Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women’s Hospital, Boston, Massachusetts 02115 USA
5Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rebecca Robbins
Laura K. Barger
4Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women’s Hospital, Boston, Massachusetts 02115 USA
5Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laura K. Barger
Elise R. Facer-Childs
1School of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Melbourne, Victoria 3800 Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elise R. Facer-Childs
Shantha M. W. Rajaratnam
1School of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Melbourne, Victoria 3800 Australia
4Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women’s Hospital, Boston, Massachusetts 02115 USA
5Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shantha M. W. Rajaratnam
Charles A. Czeisler
4Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women’s Hospital, Boston, Massachusetts 02115 USA
5Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Charles A. Czeisler
  • For correspondence: czeisler@g.harvard.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives Governments worldwide have recommended unprecedented measures to mitigate the coronavirus disease 2019 (COVID-19) pandemic. As pressure mounts to scale back these measures, understanding public compliance with and priorities for COVID-19 mitigation is critical. The main aim of this study was to assess public compliance with and support for government-imposed stay-at-home orders in nations and cities with different COVID-19 infection and death rates.

Design In this cross-sectional study, questionnaires were administered to nationally representative respondents from April 2-8, 2020.

Setting Regions with different disease prevalence included two nations [the United States (US—high) and Australia (AU—low)] and two cities [New York (NY—high) and Los Angeles (LA—low)].

Participants For adults 18 years or older residing in specified regions, eligible respondents were empaneled until representative quotas were reached for age, gender, and either race and ethnicity (US, NY, LA) or ancestry (AU), matching the 2010 US or 2016 AU census. Of 8718 eligible potential respondents, 5573 (response rate, 63.9%) completed surveys (US: 3010; NY: 507; LA: 525; AU: 1531). The median age was 47 years (range, 18-89); 3039 (54.5%) were female.

Exposure The prevalence of COVID-19 in each region (cumulative infections, deaths) as of April 8, 2020: US (458610, 15659), AU (5956, 45),1 NY (81803, 4571), LA (7530, 198).2

Main Outcomes Measures Public compliance with and attitudes regarding government-imposed stay-at-home orders were evaluated and compared between regions.

Results Of 5573 total respondents, 4560 (81.8%) reported compliance with recommended quarantine or stay-at-home policies (range of samples, 75.5%-88.2%). Despite significant disruptions of social and work life, health, and behavior, 5022 respondents (90.1%) supported government-imposed stay-at-home orders (range of samples, 88.9%-93.1%). Of these, 90.8% believe orders should last at least three more weeks or until public health or government officials recommend, with such support spanning the political spectrum.

Conclusions Public compliance with stringent quarantine and stay-at-home policies was very high, in both highly-affected (US, NY) and minimally-affected regions (AU, LA). Despite extensive disruption of respondents’ lives, the vast majority supported continuation of long-term government-imposed stay-at-home orders. These findings have important implications for policymakers grappling with the decision as to when to lift restrictions.

Competing Interest Statement

C.A.C. reports grants from Cephalon Inc., Jazz Pharmaceuticals Plc., Inc., Philips Respironics, Inc., Regeneron Pharmaceuticals, ResMed Foundation, San Francisco Bar Pilots, Sanofi S.A., Sanofi-Aventis, Inc, Schneider Inc., Sepracor, Inc, Mary Ann & Stanley Snider via Combined Jewish Philanthropies, Teva Pharmaceuticals Industries, Ltd.; and personal fees from Bose Corporation, Columbia River Bar Pilots, Ganésco Inc., Institute of Digital Media and Child Development, Klarman Family Foundation, Samsung Electronics, Quest Diagnostics, Inc., Teva Pharma Australia, Vanda Pharmaceuticals, Washington State Board of Pilotage Commissioners, Zurich Insurance Company, Ltd. In addition, C.A.C. holds a number of process patents in the field of sleep/circadian rhythms (e.g., photic resetting of the human circadian pacemaker) and holds an equity interest in Vanda Pharmaceuticals, Inc. Since 1985, C.A.C. has also served as an expert on various legal and technical cases related to sleep and/or circadian rhythms, including those involving the following commercial entities: Casper Sleep Inc., Comair/Delta Airlines, Complete General Construction Company, FedEx, Greyhound, HG Energy LLC, Purdue Pharma, LP, Steel Warehouse Inc., Stric-Lan Companies LLC, Texas Premier Resource LLC, and United Parcel Service (UPS). CAC receives royalties from Philips Respironics, Inc. for the Actiwatch-2 and Actiwatch- Spectrum devices. Interests for C.A.C. were reviewed and managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies.

Clinical Trial

Not applicable.

Funding Statement

This study was supported in part by the Institute for Breathing and Sleep, Austin Health; the Turner Institute for Brain and Mental Health, Monash University; and by a gift to the Harvard Medical School from Philips Respironics. M.É.C. was supported by a 2020 Fulbright Future Scholarship funded by the Kinghorn Foundation through the Australian-American Fulbright Commission. L.K.B. and C.A.C. were supported in part by the National Institute of Occupational Safety and Health R01-OH-010300. C.A.C. serves as the incumbent of an endowed professorship provided to Harvard Medical School by Cephalon, Inc. The funders were not involved in the design and conduct of the study, the collection, preparation, or interpretation of the data, or the preparation or approval of the manuscript.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 24, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19: Public Compliance with and Public Support for Stay-at-Home Mitigation Strategies
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19: Public Compliance with and Public Support for Stay-at-Home Mitigation Strategies
Mark É. Czeisler, Mark E. Howard, Rebecca Robbins, Laura K. Barger, Elise R. Facer-Childs, Shantha M. W. Rajaratnam, Charles A. Czeisler
medRxiv 2020.04.22.20076141; doi: https://doi.org/10.1101/2020.04.22.20076141
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
COVID-19: Public Compliance with and Public Support for Stay-at-Home Mitigation Strategies
Mark É. Czeisler, Mark E. Howard, Rebecca Robbins, Laura K. Barger, Elise R. Facer-Childs, Shantha M. W. Rajaratnam, Charles A. Czeisler
medRxiv 2020.04.22.20076141; doi: https://doi.org/10.1101/2020.04.22.20076141

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (47)
  • Cardiovascular Medicine (415)
  • Dentistry and Oral Medicine (70)
  • Dermatology (49)
  • Emergency Medicine (145)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4874)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (678)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (633)
  • Health Policy (322)
  • Health Systems and Quality Improvement (208)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5358)
  • Intensive Care and Critical Care Medicine (332)
  • Medical Education (94)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (690)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (127)
  • Occupational and Environmental Health (209)
  • Oncology (443)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (90)
  • Pain Medicine (35)
  • Palliative Medicine (17)
  • Pathology (130)
  • Pediatrics (196)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (782)
  • Public and Global Health (1823)
  • Radiology and Imaging (325)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)